HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

BKHA — Black Hawk Acquisition Corporation

BKHA (Black Hawk Acquisition Corporation) stock: $5.63, $0.0M cash, $23.4M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

We were formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” On April 26, 2025, we entered into a Business Combination Agreement with Vesicor Therapeutics, Inc. and BH Merger Sub, Inc., pursuant to which we intend to consummate a business combination (the “Business Combination”), subject to the satisfaction of customary closing conditions.

Source: 10-K FY2025 via SEC EDGAR

Share price
$5.63
Market cap
Not disclosed
Cash
$0.0M
Enterprise value
Not disclosed

Balance sheet

Cash$0.0M
Debt$0.0M
Net cash$0.0M
Enterprise valueNot disclosed
Basic shares4.2M shares
Fully diluted shares4.2M shares
Fully diluted market cap$23.4M
Cash per share$0.00
Quarterly burn$0.1M
Cash runway0.1 quarters

Cash figures as of 2026-08-31. Database snapshot: 2026-11-07.

Share structure

Common
4.2M
Pre-funded warrants
0.0M
Options
0.0M
RSUs
0.0M
Warrants
0.0M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
0.0M
FDSO
4.2M

Cap table as of 2026-10-06.

Price history

Loading BKHA daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego